BMS-945429
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BMS-945429, covering 2021-11-05 to 2021-12-06. Get the full timeline:
Most recent: Clinical Trial Update: Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate [Phase 2]